Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Novartis Pharmaceuticals UK Limited, Trading as Geigy Pharmaceuticals, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom
Voltarol Rapid Tablets 50mg.
Pharmaceutical Form |
---|
Coated tablet. |
Each tablet contains 50mg of diclofenac potassium.
Chemical name: Potassium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate
For a full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
List of Excipients |
---|
Silica, colloidal anhydrous (Aerosil 200) |
PVC/PE/PVdC blister strips containing 2, 3, 28 or 30 tablets.
(PVC 237.5-262.5 micron, PE 22.5-27.5 micron, PVdC 68.3-75.4 micron, aluminium foil 26-34 micron)
Novartis Pharmaceuticals UK Limited, Trading as Geigy Pharmaceuticals, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom
PL 00101/0482
17 February 1998
Drug | Countries | |
---|---|---|
VOLTAROL | Estonia, Ireland, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.